Neurocrine Biosciences, Inc. receives second milestone payment of $20 million under Abbott Laboratories collaboration agreement (BioSpace GenePool, 5 October 2011)

11 Oct 2011


Neurocrine Biosciences, Inc. has announced it has achieved its second milestone in its collaboration with Abbott for elagolix and next-generation gonadotropin releasing hormone receptor antagonists.

Full article


Share this story